Antonio Gangemi1, Barbara Colombo2, Rosa Angela Fabio3. 1. Department of Cognitive Science and Education, University of Messina, Messina, ME, Italy. 2. Neuroscience Lab, Champlain College, Burlington, VT, 05402, USA. bcolombo@champlain.edu. 3. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Abstract
BACKGROUND: Non-invasive brain stimulation is an effective treatment for Alzheimer's disease. AIMS: The purpose of the two studies presented here is to compare the short- and long-term effects of transcranial direct current stimulation (t-DCS) on two samples of advanced AD patients. METHODS: In Study 1 26 patients were involved in a 10-day anodal vs. sham tDCS intervention stimulating the left frontotemporal cortex. A pre-post test assessment was run using two different neurocognitive tests and EEG data. The same protocol was used in Study 2, which involved 18 different patients who underwent the same intervention 10 days a month for 8 months. RESULTS: Results confirmed how the t-DCS intervention was effective both in the short- and the long-term to slow down the progression of AD on specific neurophysiological domains and, to a certain extent, on neurophysiological activity. Discussion tDCS appear to be effective and to affect differently neurocognitive and neurophysiological functions when comparing short and long-term outcomes. Conclusions Anodal-tDCS is an effective way to slow down the progression of Alzheimer's both in the short and long term. It can also affect the EEG patterns, but this requires a more protracted intervention.
BACKGROUND: Non-invasive brain stimulation is an effective treatment for Alzheimer's disease. AIMS: The purpose of the two studies presented here is to compare the short- and long-term effects of transcranial direct current stimulation (t-DCS) on two samples of advanced AD patients. METHODS: In Study 1 26 patients were involved in a 10-day anodal vs. sham tDCS intervention stimulating the left frontotemporal cortex. A pre-post test assessment was run using two different neurocognitive tests and EEG data. The same protocol was used in Study 2, which involved 18 different patients who underwent the same intervention 10 days a month for 8 months. RESULTS: Results confirmed how the t-DCS intervention was effective both in the short- and the long-term to slow down the progression of AD on specific neurophysiological domains and, to a certain extent, on neurophysiological activity. Discussion tDCS appear to be effective and to affect differently neurocognitive and neurophysiological functions when comparing short and long-term outcomes. Conclusions Anodal-tDCS is an effective way to slow down the progression of Alzheimer's both in the short and long term. It can also affect the EEG patterns, but this requires a more protracted intervention.
Authors: Rosa Angela Fabio; Lucia Billeci; Giulia Crifaci; Emilia Troise; Gaetano Tortorella; Giovanni Pioggia Journal: Res Dev Disabil Date: 2016-02-06
Authors: Paulo Sergio Boggio; Roberta Ferrucci; Francesca Mameli; Débora Martins; Oscar Martins; Maurizio Vergari; Laura Tadini; Elio Scarpini; Felipe Fregni; Alberto Priori Journal: Brain Stimul Date: 2011-07-27 Impact factor: 8.955
Authors: Eman M Khedr; Nageh F El Gamal; Noha Abo El-Fetoh; Hosam Khalifa; Elham M Ahmed; Anwer M Ali; Mostafa Noaman; Ahmed Abd El-Baki; Ahmed A Karim Journal: Front Aging Neurosci Date: 2014-10-09 Impact factor: 5.750
Authors: Arianna Menardi; Simone Rossi; Giacomo Koch; Harald Hampel; Andrea Vergallo; Michael A Nitsche; Yaakov Stern; Barbara Borroni; Stefano F Cappa; Maria Cotelli; Giulio Ruffini; Georges El-Fakhri; Paolo M Rossini; Brad Dickerson; Andrea Antal; Claudio Babiloni; Jean-Pascal Lefaucheur; Bruno Dubois; Gustavo Deco; Ulf Ziemann; Alvaro Pascual-Leone; Emiliano Santarnecchi Journal: Ageing Res Rev Date: 2021-12-30 Impact factor: 11.788
Authors: Celina S Liu; Nathan Herrmann; Bing Xin Song; Joycelyn Ba; Damien Gallagher; Paul I Oh; Susan Marzolini; Tarek K Rajji; Jocelyn Charles; Purti Papneja; Mark J Rapoport; Ana C Andreazza; Danielle Vieira; Alex Kiss; Krista L Lanctôt Journal: BMC Geriatr Date: 2021-12-04 Impact factor: 3.921